C O M M U N I C A T I O N S
Chart 2a
Scheme 1a
a Reagents and conditions: (a) Boc-Lys(CBz)-SPh, PhSH, K2CO3,
DMSO, CH3CN, 23f90 °C, 80% (19), 76% (20); (b) OsO4, (nBu4N)2IO4,
2,6-lutidine, acetone, H2O, 23 °C; TFA, CH3CN, 23 °C, 70% (from 15),
82% (from 17); (c) (py-H)2CeCl6, THF, H2O, 23 °C, 83% (21), 79% (22);
(d) H-Glu(Bn)-OBn, Et3N, (py-H)2CeCl6, CH2Cl2, 23 °C, 72% (23), 74%
(24).
to new building blocks for glycopeptide synthesis, with particular
attention to the challenging R-GalNAc-Ser motif.28
Acknowledgment. This research was supported by the NIH-
NIGMS (GM58833). A portion of this work was performed in the
Dept. of Chemistry, University of Illinois, Urbana, IL.
Supporting Information Available: Experimental details. This
a Reagents and conditions: (A) KH, 18-cr-6, DMF, 0 °C; (B) NaH, PBu3,
1,4-dioxane, 23 °C.
References
(1) Hang, H. C.; Bertozzi, C. R. Bioorg. Med. Chem. 2005, 13, 5021–5034.
(2) Hollingsworth, M. A.; Swanson, B. J. Nat. ReV. Cancer 2004, 4, 45–60.
(3) Bouvet, V.; Ben, R. N. Cell Biochem. Biophys. 2003, 39, 133–144.
(4) Zachara, N. E.; Hart, G. W. Chem. ReV. 2002, 102, 431–438.
(5) Endo, T. Biochim. Biophys. Acta 1999, 1473, 237–246.
(6) Lemieux, R. U.; Ratcliffe, R. M. Can. J. Chem. 1979, 57, 1244–1251.
(7) Benakli, K.; Zha, C. X.; Kerns, R. J. J. Am. Chem. Soc. 2001, 123, 9461–
9462.
dioxane). Anomeric stereoselective couplings were effected with
aziridinyl amides 11 or 12 to furnish the conjugates 13, 14, 15r/ꢀ
(15r ) Tn-antigen), 16 (T-antigen), 17r/ꢀ, and 18r/ꢀ. Notably,
the glycosyl-adducts 16 and 18 illustrate aziridinolysis with a
disaccharide nucleophile and a dipeptide-derived electrophile,
respectively.
(8) Winterfeld, G. A.; Schmidt, R. R. Angew. Chem., Int. Ed. 2001, 40, 2654–
2657.
(9) Hu, X. E. Tetrahedron 2004, 60, 2701–2743.
The utility of pNs-Azy-NHABn (11), beyond its role as a suitable
electrophile, lies in its ability to undergo useful N- and C-terminal
derivatization following aziridinolysis (Scheme 1). Thiol-mediated
N-pNs deprotection is a standard procedure;23,24 however, modi-
fication of this protocol by performing it in the presence of a suitable
thioester leads to in situ N-acylation.25 For example, a direct
N-terminus extension of GalNAc adduct 15 (Scheme 1) to dipeptide
19 was accomplished by treatment with PhSH and Boc-Lys(Cbz)-
SPh. Conversely, selective liberation of the C-terminus of 15 is
possible via oxidative alkene cleavage26 of the ABn protective group
and Schiff base formation to generate the cyclic N-acyl-enamide.
Subsequent CeIV-mediated benzylic oxidation27 provides the tran-
sient N-acyl-isoquinolinium species, which can either (1) undergo
in situ hydrolysis to provide the carboxylic acid 21 as a monomer
for solution or solid-phase peptide synthesis, or (2) engage in direct
C-terminus extension via acyl transfer to an amino group, such as
that in H-Glu(Bn)-OBn, to furnish dipeptide 23. Similar outcomes
for amino acid functionalization can be seen with the protected
ꢀ-GlcNAc-Ser conjugate (17f20, 22, 24).
(10) Kogami, Y.; Okawa, K. Bull. Chem. Soc. Jpn. 1987, 60, 2963–2965.
(11) Kroger, L.; Henkensmeier, D.; Schafer, A.; Thiem, J. Bioorg. Med. Chem.
Lett. 2004, 14, 73–75.
(12) Li, P.; Evans, C. D.; Joullie, M. M. Org. Lett. 2005, 7, 5325–5327.
(13) Product anomeric selectivity is independent of original hemiacetal config-
uration.
(14) Schmidt, R. R. Angew. Chem., Int. Ed. Engl. 1986, 25, 212–235.
(15) Schmidt, R. R.; Esswein, A. Angew. Chem., Int. Ed. Engl. 1988, 27, 1178–
1180.
(16) Hodosi, G.; Kovac, P. J. Am. Chem. Soc. 1997, 119, 2335–2336.
(17) Roth, W.; Pigman, W. J. Am. Chem. Soc. 1960, 82, 4608–4611.
(18) Lubineau, A.; Bienayme, H.; Le Gallic, J. J. Chem. Soc., Chem. Commun.
1989, 1918–1919.
(19) Lubineau, A.; Escher, S.; Alais, J.; Bonnaffe, D. Tetrahedron Lett. 1997,
38, 4087–4090.
(20) Vauzeilles, B.; Dausse, B.; Palmier, S.; Beau, J.-M. Tetrahedron Lett. 2001,
42, 7567–7570.
(21) Both aziridine-2-carboxylate and its ester derivatives were incompatible
electrophiles. Additionally, pyranoses bearing peripheral acetates were found
to be inappropriate nucleophiles.
(22) Fan, R. H.; Hou, X. L. J. Org. Chem. 2003, 68, 726–730.
(23) Maligres, P. E.; See, M. M.; Askin, D.; Reider, P. J. Tetrahedron Lett.
1997, 38, 5253–5256.
(24) Kan, T.; Fukuyama, T. Chem. Commun. 2004, 353–359.
(25) For a related protocol involving dinitrobenzenesulfonamides and thiocar-
boxylates, see: Crich, D.; Sana, K.; Guo, S. Org. Lett. 2007, 9, 4423–4426.
(26) Yu, W.; Mei, Y.; Kang, Y.; Hua, Z.; Jin, Z. Org. Lett. 2004, 6, 3217–3219.
(27) Uchimaru, T.; Narasaka, K.; Mukaiyama, T. Chem. Lett. 1981, 1551–1554.
(28) Adaptation of this method to the more sterically demanding Thr-derived
conjugates is currently underway.
The feasibility of aziridine 2-carboxamide ring-opening with
pyranose C1-O-nucleophiles has been established. The process
provides good levels of anomeric selectivity and is tolerant to the
native C2-NHAc group. This, in addition to novel methods for N-
and C-terminus extension of amino acids, should provide access
JA804589J
9
J. AM. CHEM. SOC. VOL. 130, NO. 46, 2008 15229